Population Pharmacokinetics and Exposure–Response Modeling of Golimumab in Adults With Moderately to Severely Active Ulcerative Colitis
Omoniyi J. Adedokun, Zhenhua Xu, Sam Liao, Richard Strauß, Walter Reinisch, Brian G. Feagan, William J. Sandborn
Topics & Concepts
GolimumabMedicinePharmacokineticsPopulationUlcerative colitisInternal medicineAdverse effectPharmacologyGastroenterologyEtanerceptTumor necrosis factor alphaDiseaseEnvironmental healthInflammatory Bowel DiseaseRheumatoid Arthritis Research and TherapiesBiosimilars and Bioanalytical Methods